Autoimmune Association: Grants and Programs Guide

Reader task: Understand the governance, research mission, and funding mechanisms of the Autoimmune Association, and evaluate eligibility and application procedures for the Virginia T. Ladd Young Investigators Program.

Disclaimer: This guide covers nonprofit grant administration, investigator eligibility, and research governance. It does not provide individual medical advice, clinical diagnosis, or therapeutic dosing.

The Autoimmune Association is the leading global nonprofit dedicated to autoimmune disease research, advocacy, and patient education. Rather than focusing exclusively on a single illness, the association addresses the biological mechanisms of autoimmunity across more than 100 conditions. For biomedical researchers and grant administrators, the association serves as an advocate for federal research appropriations and a direct seed funder through the Virginia T. Ladd Young Investigators Program.

What it is and who runs it

The Autoimmune Association was founded in 1991 by Virginia T. Ladd as the American Autoimmune Related Diseases Association (AARDA). On its 30th anniversary, the organization rebranded as the Autoimmune Association to reflect its international scope across more than 60 countries.

The organization is a 501(c)(3) tax-exempt public charity (EIN: 38-3027574) with a 4-star Charity Navigator rating. Its mission operates across four strategic pillars: Research, Advocacy, Public Awareness, and Services and Education.

Executive leadership is directed by President and CEO Molly Murray, CAE, and COO Laura Simpson, MBA. Governance is provided by an independent Board of Directors, while grant evaluations are guided by a Scientific Advisory Board of academic immunologists and rheumatologists.

The association leads the National Coalition of Autoimmune Patient Groups (NCAPG) and coordinates the Autoimmune Research Network (ARNet), a patient registry facilitating clinical trial recruitment. Through sustained advocacy, the association helped secure the 2023 congressional establishment of the Office of Autoimmune Disease Research (OADR) within the Office of Research on Women’s Health (ORWH) at the NIH. Research administrators can contextualize this work with our guides to the Foundation for the National Institutes of Health (FNIH) and broad immunology research fundamentals.

Eligibility

Eligibility for Autoimmune Association research grants is structured to support emerging scientists, as described on the official page on 8 November 2026. The Virginia T. Ladd Young Investigators Program maintains specific requirements:

Career Stage and Age Limit: Applicants must be early-career scientists under 45 years of age at submission. Eligible ranks include postdoctoral research fellows and junior faculty (such as Instructors or Assistant Professors). Established, tenured investigators are not eligible.
Terminal Degree: Applicants must hold a recognized doctoral degree, such as an MD, PhD, MD/PhD, DO, or equivalent research doctorate.
Institutional Affiliation: Candidates must be affiliated with an accredited, nonprofit academic research institution, medical center, or university. Grants are disbursed to and administered by the institution’s sponsored programs office, not directly to individuals.
Scientific Scope: Proposals must examine basic autoimmunity issues. The association defines this as research focused on mechanisms, biomarkers, or immune pathways that benefit the broader autoimmune community across multiple conditions, rather than a single disease compartment.
Role: The applicant must serve as the primary principal investigator (PI) with dedicated laboratory space and institutional backing.

What it funds or requires

The Virginia T. Ladd Young Investigators Program provides pilot support to generate preliminary data for future federal grant proposals, as described on the official page on 8 November 2026:

Award Amount and Duration: Grants provide up to $20,000 in direct support for a one-year performance period.
Allowable Direct Costs: Funds cover consumable laboratory supplies, assay reagents, core facility usage fees, and research assistant or technician stipends.
Unallowable Costs: Indirect costs (facilities and administrative overhead) are not permitted on these pilot grants. Funds cannot be used for institutional overhead, office equipment, or clinical patient care expenses.
Target Outcome: The primary programmatic goal is to generate proof-of-concept preliminary data to support competitive federal applications, including an NIH R01 research project grant.
Regulatory Compliance: Host institutions must provide active IACUC approval for animal protocols or IRB approval for human subject and biospecimen studies before funds are released.

Application or compliance steps

Applying for and administering an award involves coordinated steps between the investigator and the institution:

Review Active RFP: Examine the active request for proposals on autoimmune.org or partnered portals (e.g., ProposalCentral) to verify current focus areas and page limits.
Formulate Cross-Cutting Aims: Develop a 1-year research aim investigating cross-disease autoimmunity mechanisms, such as immune tolerance breakdown or autoantibody generation.
Assemble Application Dossier: Prepare the abstract, specific aims, research strategy, itemized budget, budget justification, biosketch, and letters of support.
Secure Institutional Routing: Route the proposal through the university’s Office of Sponsored Programs for institutional sign-off and compliance verification.
Submit Electronically: Transmit the complete proposal through the designated submission system prior to the deadline.
Undergo Peer Review: Submissions are evaluated by the Scientific Advisory Board based on innovation, methodology, and relevance to the autoimmune field.
Execute Agreement and Reporting: Upon award notification, the institution executes the contract. The PI must submit a final technical progress report and financial closeout accounting for all expenditures.

Typical timeline phases

Autoimmune Association funding follows procedural phases rather than fixed calendar dates. Specific dates vary each cycle, as described on the official page on 8 November 2026:

Phase 1: RFP Release: The association announces the cycle, opening the application portal for approximately 6 to 8 weeks.
Phase 2: Administrative Triage: Proposals undergo initial compliance screening for age limits, doctoral degrees, and institutional eligibility.
Phase 3: Scientific Peer Review: The Scientific Advisory Board conducts independent peer evaluations over an 8- to 12-week review window.
Phase 4: Award Notification and Contracting: Selection notices are sent to prospective PIs and institutional officials, with 4 weeks to complete institutional contracting.
Phase 5: Performance Period: Awardees carry out experimental protocols during the 12-month performance term.
Phase 6: Project Closeout: Within 60 to 90 days after project termination, the PI submits scientific summaries and financial reconciliations.

Common mistakes

Applicants and grant administrators should avoid these common submission errors:

Single-Disease Focus: Proposing research restricted to a single condition without connecting findings to common autoimmune pathways across diseases.
Exceeding Career Limits: Applying when the investigator is 45 years of age or older, or holding senior tenured faculty status.
Budgeting Indirect Costs: Requesting university F&A overhead rates, which leads to administrative disqualification.
Bypassing Institutional Sign-Off: Submitting applications directly as an individual rather than through the university’s sponsored research office.
Overly Broad Scope: Designing an ambitious multi-year project that exceeds the $20,000 budget and one-year performance timeline.
Omitted Mentor Documentation: Failing to include formal support letters verifying laboratory resources and protected time for postdoctoral applicants.

Related programs

The Autoimmune Association’s funding fits within a broader landscape of early-career biomedical and immunology grant programs:

Program and Funder	Award Amount and Duration	Target Career Stage	Primary Research Scope
Virginia T. Ladd Young Investigators Program (Autoimmune Association)	Up to $20,000 (1 year)	Postdocs and junior faculty under 45	Basic cross-disease autoimmunity mechanisms and immune tolerance
ANRF Research Grants (Arthritis National Research Foundation)	Up to $125,000/yr (1 to 2 years)	Postdocs and junior faculty	Mechanisms of arthritis and related autoimmune connective tissue diseases
Gary S. Gilkeson Career Development Award (Lupus Research Alliance)	Up to $300,000 total (3 years)	Postdocs and early-stage clinician-scientists	Translational and basic research in systemic lupus erythematosus
Career Development Award (Crohn’s & Colitis Foundation)	Up to $100,000/yr (3 years)	Junior faculty	Pathophysiology and clinical aspects of inflammatory bowel disease
NIH K-Series Mentored Awards (National Institutes of Health)	$100,000 to $150,000/yr salary plus supplies (3 to 5 years)	Mentored early-career investigators	Career development toward independence, including mentored research scientist career development awards

FAQ

What was the Autoimmune Association formerly called?

The Autoimmune Association was founded in 1991 as the American Autoimmune Related Diseases Association (AARDA). It rebranded in 2021 on its 30th anniversary to reflect its international scope and collaborative global mission.

Does the Autoimmune Association fund clinical trials directly?

No. The association does not directly fund large-scale interventional clinical trials through its investigator grants. It focuses on basic seed research and supports trial recruitment via its patient registry, ARNet (Autoimmune Research Network).

Can international researchers apply for Autoimmune Association grants?

Applicants must be affiliated with an accredited academic or nonprofit research institution capable of administering sponsored research funds. Specific geographic parameters are defined in each cycle’s request for proposals.

How does the Autoimmune Association interact with the NIH Office of Autoimmune Disease Research?

The Autoimmune Association led advocacy efforts resulting in the 2023 establishment of the Office of Autoimmune Disease Research (OADR) at the NIH. As an independent 501(c)(3) nonprofit, the association collaborates with federal agencies to communicate patient priorities and encourage cross-institute research coordination.

Are indirect costs allowed on the Virginia T. Ladd Young Investigator Grant?

No. Institutional indirect costs (facilities and administrative overhead) are not permitted on these seed grants. All awarded funds must support direct project research costs.

Sources

Autoimmune Association: Official Governance, History, and Mission Overview. Available at: https://autoimmune.org/about-us/ (Accessed: 8 November 2026).
Autoimmune Association: Research Programs and Young Investigator Grant Cycles. Available at: https://autoimmune.org/blog/grant-applications-now-available/ and https://autoimmune.org/research/ (Accessed: 8 November 2026).
Autoimmune Association: Strategic Initiatives and Office of Autoimmune Disease Research (OADR) Briefing. Available at: https://autoimmune.org/research/aa-initiatives/ and https://autoimmune.org/research/oadr/ (Accessed: 8 November 2026).
National Institutes of Health, Office of Research on Women’s Health: Office of Autoimmune Disease Research (OADR). Available at: https://orwh.od.nih.gov/research/autoimmune-disease-research (Accessed: 8 November 2026).
Charity Navigator: Autoimmune Association Nonprofit Evaluation and Form 990 Metrics (EIN 38-3027574). Available at: https://www.charitynavigator.org/ (Accessed: 8 November 2026).